Global Patent Index - EP 1845963 A2

EP 1845963 A2 2007-10-24 - ISOLATION OF N-BUTYLBENZENESULFONAMIDE, SYNTHESIS OF BENZENESULFONAMIDE DERIVATIVES, AND USE OF N-BUTYLBENZENESULFONAMIDE AND BENZENESULFONAMIDE DERIVATIVES FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA AND/OR PROSTATE CARCINOMA

Title (en)

ISOLATION OF N-BUTYLBENZENESULFONAMIDE, SYNTHESIS OF BENZENESULFONAMIDE DERIVATIVES, AND USE OF N-BUTYLBENZENESULFONAMIDE AND BENZENESULFONAMIDE DERIVATIVES FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA AND/OR PROSTATE CARCINOMA

Title (de)

ISOLIERUNG VON N-BUTYLBENZOLSULFONAMID, SYNTHESE VON BENZOLSULFONAMID-DERIVATEN SOWIE VERWENDUNG VON N-BUTYLBENZOLSULFONAMID UND BENZOLSULFONAMID-DERIVATEN ZUR BEHANDLUNG DER BENIGNEN PROSTATAHYPERPLASIE UND/ODER DES PROSTATAKARZINOMS

Title (fr)

ISOLEMENT DE N-BUTYLBENZOLSULFONAMIDE, SYNTHESE DE DERIVES DE BENZOLSULFONAMIDE ET UTILISATION DE N-BUTYLBENZOSULFONAMIDE , SYNTHESE BUTYLBENZOLSULFONAMIDES ET DE DERIVES DE BENZOLSULFONAMIDE PERMETTANT DE TRAITER L'HYPERPLASIE BENIGNE DE LA PROSTATE ET/OU DU CARCINOME DE LA PROSTATE

Publication

EP 1845963 A2 (DE)

Application

EP 06706462 A

Priority

  • EP 2006000746 W
  • DE 102005005397 A

Abstract (en)

[origin: CA2596618C] The invention relates to a method for isolating N-butylbenzenesulfonamide (NBBS) from biological material, especially prunus africana, the chemical synthesis of benzenesulfonamide derivatives, and the use of NBBS and benzenesulfonamide derivatives for the treatment of or producing medicaments for the treatment of benign prostate hyperplasia and/or prostate carcinoma and as a basic substance for the development of agents used for treating said diseases.

IPC 8 full level (invention and additional information)

A61K 31/18 (2006.01); A61K 36/00 (2006.01); A61P 13/08 (2006.01); A61P 35/00 (2006.01)

CPC (invention and additional information)

A61K 36/736 (2013.01); A61K 31/18 (2013.01)

Citation (search report)

See references of WO 2006081994A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK YU

EPO simple patent family

DE 102005005397 A1 20060810; DE 102005005397 B4 20080821; AU 2006210040 A1 20060810; AU 2006210040 B2 20110414; AU 2006210040 B9 20110526; BR PI0606563 A2 20091117; CA 2596618 A1 20060810; CA 2596618 C 20130507; CN 101111240 A 20080123; CN 101111240 B 20110921; EP 1845963 A2 20071024; JP 2008528647 A 20080731; JP 5191238 B2 20130508; KR 20070100844 A 20071011; MX 2007009402 A 20070925; US 2008177107 A1 20080724; US 7700654 B2 20100420; WO 2006081994 A2 20060810; WO 2006081994 A3 20070322; ZA 200706061 B 20080730

INPADOC legal status


2014-12-31 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20140801

2008-12-24 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20081121

2008-05-14 [DAX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT (TO ANY COUNTRY) DELETED

2007-10-24 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20070720

2007-10-24 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

2007-10-24 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Countries: AL BA HR MK YU